Day: January 14, 2025

Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors

Written by Customer Service on January 14, 2025. Posted in Public Companies.

HUNTSVILLE, AL, Jan. 14, 2025 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery technology, today announced the appointment of Karen J. Wilson to the Board of Directors. “We are excited to welcome Karen to the Board of Directors. Karen’s financial expertise and deep understanding of the biotech landscape will play a crucial role in guiding our strategic initiatives and delivering transformative therapies to patients,” said Steve Ledger, Serina’s Chief Executive Officer. Ms. Wilson brings over three decades of leadership experiences in the life sciences sector. She currently serves as a board director for Connect Biopharma Holdings Limited, Elicio Therapeutics, Inc. and LAVA Therapeutics N.V. Previously,...

Eldorado Gold Delivers Gold Production of 520,293 Ounces in 2024, Above the Midpoint of Tightened Guidance, With Solid Fourth Quarter Preliminary Gold Production of 155,669 Ounces; Provides Skouries Construction Progress and Conference Call Details

Written by Customer Service on January 14, 2025. Posted in Public Companies.

(All dollar figures are in US dollars, unless otherwise stated) VANCOUVER, British Columbia, Jan. 14, 2025 (GLOBE NEWSWIRE) — Eldorado Gold Corporation (“Eldorado” or “the Company”) announces fourth quarter 2024 preliminary gold production of 155,669 ounces, and full year preliminary gold production of 520,293 ounces, delivering 7% annual production growth over 2023. Fourth quarter production was very strong at the Lamaque Complex and Kisladag, while Efemcukuru continued to deliver on expectations. Overall production was well in line with the Company’s guidance of a stronger second half in 2024. Full year preliminary production was above the midpoint of the tightened guidance range of 505,000 to 530,000 ounces, as announced in the third quarter 2024 results news release. Detailed production, by asset, is outlined in the table below. 2024...

W&T Offshore Prices $350 Million Senior Second Lien Notes Offering

Written by Customer Service on January 14, 2025. Posted in Public Companies.

HOUSTON, Jan. 14, 2025 (GLOBE NEWSWIRE) — W&T Offshore, Inc. (NYSE: WTI) (“W&T Offshore” or the “Company”) today announced the pricing of its previously announced offering of $350 million in aggregate principal amount of 10.750% senior second lien notes due 2029 (the “Notes”) at par in a private offering that is exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). The closing of the offering of the Notes is expected to occur on January 28, 2025, subject to customary closing conditions. The Company intends to use the net proceeds of the offering, along with cash on hand, to (i) purchase for cash pursuant to a tender offer, the Company’s outstanding 11.750% Senior Second Lien Notes due 2026 (the “2026 Senior Second Lien Notes”) that are validly tendered pursuant to the terms thereof...

Gatos Silver Reports Stockholder Approval of Merger with First Majestic

Written by Customer Service on January 14, 2025. Posted in Mergers And Acquisitions.

VANCOUVER, British Columbia, Jan. 14, 2025 (GLOBE NEWSWIRE) — Gatos Silver, Inc. (NYSE:GATO) (TSX:GATO) (“Gatos Silver” or the “Company”) today announced that Gatos Silver’s stockholders have voted to adopt the proposal related to the previously announced merger agreement between First Majestic Silver Corp. (“First Majestic”) and Gatos Silver (the “Merger Resolution”). The vote was held at Gatos Silver’s special stockholders meeting earlier today. The Merger Resolution was required to be approved by Gatos Silver stockholders representing a majority of the outstanding shares of common stock of Gatos Silver (“Gatos Silver Shares”). Approximately 71.3% of the outstanding Gatos Silver Shares were voted in favor of the Merger Resolution. The final voting results will be reported on a Form 8-K filed with the Securities and Exchange Commission. In...

Stride Announces Date for Second Quarter Fiscal Year 2025 Earnings Call

Written by Customer Service on January 14, 2025. Posted in Public Companies.

RESTON, Va, Jan. 14, 2025 (GLOBE NEWSWIRE) — Stride Inc. (NYSE: LRN) announced today it plans to discuss its second quarter fiscal year 2025 financial results during a conference call scheduled for Tuesday, January 28, 2025 at 5:00 p.m. eastern time (ET). A live webcast of the call will be available at https://events.q4inc.com/attendee/534139423. To participate in the live call, investors and analysts should dial (800) 715-9871 (domestic) or +1 (646) 307-1963 (international) and provide the conference ID number 8901384. Please access the website at least 15 minutes prior to the start of the call. A replay of the call will be posted at https://events.q4inc.com/attendee/534139423 as soon as it is available.About Stride Inc. Stride Inc. (NYSE: LRN) is redefining lifelong learning with innovative, high-quality education solutions....

Crown Announces Results of Special Meeting of Stockholders

Written by Customer Service on January 14, 2025. Posted in Public Companies.

LOS ANGELES, Jan. 14, 2025 (GLOBE NEWSWIRE) — Crown Electrokinetics Corp. (NASDAQ: CRKN) (“Crown” or the “Company”), a leading provider of innovative technology infrastructure solutions that benefit communities and the environment, today announced the voting results from its Special Meeting of Stockholders held on January 14, 2025. Crown’s shareholders approved all proposals presented during the meeting, including the authorization of up to a 1-for-200 reverse stock split of its common stock and ratification of its independent registered public accounting firm. These approvals provide Crown with the flexibility to meet its corporate objectives, including maintaining compliance with Nasdaq’s listing requirements. Shareholder approval of the reverse stock split has given the Board of Directors the discretion to...

First Commonwealth to Host Fourth Quarter and Full-Year 2024 Earnings Conference Call on Wednesday, January 29, 2025

Written by Customer Service on January 14, 2025. Posted in Public Companies.

INDIANA, Pa., Jan. 14, 2025 (GLOBE NEWSWIRE) — First Commonwealth Financial Corporation (NYSE: FCF) announced today that it will host a conference call on Wednesday, January 29, 2025 at 2:00 p.m. Eastern Time to discuss financial results for the quarter ended December 31, 2024. The call will be hosted by T. Michael Price, President and Chief Executive Officer. He will be joined by James R. Reske, Executive Vice President and Chief Financial Officer, Jane Grebenc, Executive Vice President and Chief Revenue Officer and Brian J. Sohocki, Executive Vice President and Chief Credit Officer. First Commonwealth will issue a press release reporting its Fourth Quarter 2024 financial results after the market closes on Tuesday, January 28, 2025. Conference Call InformationWhat: First Commonwealth Financial Corporation Fourth Quarter...

Lotus Technology Announces Preliminary Delivery Results of 2024

Written by Customer Service on January 14, 2025. Posted in Public Companies.

NEW YORK, Jan. 14, 2025 (GLOBE NEWSWIRE) — Lotus Technology Inc. (“Lotus” or the “Company”), a leading global intelligent and luxury mobility provider, today announced its preliminary vehicle delivery results for the full year of 2024. Lotus delivered 12,065 vehicles1 in 2024, representing a year-on-year increase of over 70% and boasting the top growth rate among leading luxury brands2. China contributed approximately 25% of the total global deliveries in 2024. In 2025, the Company aims to increase global deliveries by 20% with a 25-28% contribution from China. Lotus also successfully reclaimed the proprietary rights of the LOTUS roundel, LOTUS word mark and the Chinese character of Lotus (“莲花”) in China, achieving consistency in terms of its trademark across the world. Note 1: Invoiced deliveries, including commissioned...

Context Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of CTIM-76

Written by Customer Service on January 14, 2025. Posted in Public Companies.

CTIM-76 Phase 1 trial focused on CLDN6-positive gynecologic and testicular cancers Trial marks key milestone in driving pipeline progress PHILADELPHIA, Jan. 14, 2025 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing T cell engagers for solid tumors, today announced that the first patient has been dosed in its Phase 1 clinical trial evaluating CTIM-76, a Claudin 6 (“CLDN6”) x CD3 T cell engaging bispecific antibody. The Phase 1 dose escalation and expansion trial is enrolling patients with CLDN6-positive gynecologic and testicular cancers. The Company anticipates sharing initial data for the CTIM-76 Phase 1 trial in the first half of 2026. “Dosing of the first patient in the CTIM-76 Phase 1 trial represents a key advancement of our clinical pipeline,”...

Calavo Growers, Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results

Written by Customer Service on January 14, 2025. Posted in Earnings Releases And Operating Results.

SANTA PAULA, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) — Calavo Growers, Inc. (Nasdaq-GS: CVGW), a global avocado-industry leader and provider of value-added fresh food, today reported its financial results for the fiscal fourth quarter and fiscal year ended October 31, 2024. Introductory Note: In the first quarter of 2024, we concluded that the Fresh Cut (formerly RFG) business met the requirements to be classified as held for sale and discontinued operations. As a result, the financial results of that business are reported as discontinued operations in this press release. The divestiture of the Fresh Cut business occurred on August 15, 2024. Prior to the decision to divest our Fresh Cut business, the Company’s Prepared reporting segment included the Fresh Cut business unit and our guacamole business. The Fresh Cut business unit...

Day: January 14, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals